论文信息 - Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors - 字舞流文

Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors

J. Schellens | R. Rueger | M. Scheulen | V. Diéras | S. Leijen | E. Shochat | F. Kraeber-Bodéré | M. Middleton | W. Eberhardt | Zhi-xin Xu | J. Tessier | Avinash Gupta | S. Blotner | P. Tresca | V. López-Valverde | V. M. Naegelen